ESUS yields 5.47% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, ESUS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESUS + JNJ for your $10,000?
ESUS makes a leveraged bullish bet on the MSCI USA ESG Focus Indexan index that holds large- and mid-cap companies exhibiting positive ESG characteristics, while maintaining a market-like risk and return profile. Eligible securities are initially screened to exclude firms involved in tobacco, controversial weapons, fossil fuel extraction, and thermal coal power. The portfolio is then optimized to maximize its exposure to ESG factors while staying true to a market-like exposure (subject to constraints). The underlying index rebalances quarterly. As a levered product with 2x factor that resets quarterly, the fund is not a buy-and-hold investment and should not be expected to provide index leverage return on a day-to-day basis. In addition, investors should note that ESUS is an ETN, and therefore carries the credit risk of the issuer, UBS.
Full ESUS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.